Syngenta's gaff embarrasses industry and White House

Article Abstract:

The biotech industry and the White House is embarrassed, as Syngenta, Swiss agribusiness group had inadvertently mislabeled and sold Bt-10, an unapproved genetically modified (GM) corn seed, as Bt-11, to US farmers between 2001 and 2004. Details of the various problems faced by the White House, biotech industry due to the Syngenta's gaff are discussed.

Switzerland, Political aspects, Genetically modified crops

---

Bayh-Dole: If we knew then what we know now

Article Abstract:

The controversies surrounding the US Bayh-Dole Act, enacted 25 years ago, and the legislative forays designed to modify the Act's terms to achieve a variety of social or economic goals are discussed. The Bayh-Dole Act has provided the nation and the world with a large-scale experiment in how public institutions manage public assets as private goods.

Legal issues & crime, Government regulation (cont), Government regulation, Other Justice, Public Order, and Safety Activities, Legal/Government Regulation, Patent Law, Interpretation and construction, Laws, regulations and rules

---

Similar abstracts:

• Abstracts: US to safeguard 'dual-use' biology research. When less is more
• Abstracts: A regulatory patchwork-human ES cell research oversight. Embryonic stem cells pace the heart. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells
• Abstracts: Job rotation as a factor in reducing physical workload at a refuse collecting department. The physical demands upon (Dutch) fire-fighters in relation to the maximum acceptable energetic workload
• Abstracts: US court case to define EST patentability. EPO neem patent revocation revives biopiracy debate. IP litigation in China could drive innovation

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.